Compound Detail
CHEMBL4067429
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4067429 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DNXKACKCTLURQN-ACJLOTCBSA-N |
3
Targets
6
Activities
1
Assay Types
15
PK Parameters
20
Publications
0
Known Names
Molecular Properties
414.9
MW (Da)
3.23
ALogP
5
HBA
3
HBD
104.7
PSA (Ų)
0.52
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| C-X-C chemokine receptor type 2 CHEMBL2434 | IC50 | 9.0 | 8.02 | 1.0 | 4 |
| C-X-C chemokine receptor type 2 CHEMBL4105830 | IC50 | 8.23 | 8.23 | 5.9 | 1 |
| C-X-C chemokine receptor type 1 CHEMBL4029 | IC50 | 5.42 | 5.42 | 3800.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 9.1 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 5.6 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 0.79 | mL.min-1.g-1 | Homo sapiens |
| CL | 7.7 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 1.8 | mL.min-1.g-1 | Canis lupus familiaris |
| Cmax | 1089.39 | nM | Rattus norvegicus |
| Cmax | 1754.6 | nM | Canis lupus familiaris |
| F | 47.0 | % | Rattus norvegicus |
| F | 76.0 | % | Canis lupus familiaris |
| Fu | 0.027 | - | Rattus norvegicus |
| Fu | 0.123 | - | Rattus norvegicus |
| T1/2 | 4.3 | hr | Rattus norvegicus |
| T1/2 | 3.6 | hr | Canis lupus familiaris |
| Tmax | 1.0 | hr | Rattus norvegicus |
| Tmax | 1.1 | hr | Canis lupus familiaris |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| C-X-C chemokine receptor type 2 | IC50 | = | 1.0 | nM | 9.0 | Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombi... | 29406702 |
| C-X-C chemokine receptor type 2 | IC50 | = | 5.2 | nM | 8.28 | Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombi... | 29406702 |
| C-X-C chemokine receptor type 2 | IC50 | = | 5.9 | nM | 8.23 | Antagonist activity at CXCR2 in C57 mouse whole blood assessed as inhibition of ... | 29406702 |
| C-X-C chemokine receptor type 2 | IC50 | = | 40.0 | nM | 7.4 | Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROa... | 29406702 |
| C-X-C chemokine receptor type 2 | IC50 | = | 39.81 | nM | 7.4 | Antagonist activity at CXCR2 in human whole blood assessed as inhibition of GROa... | 29406702 |
| C-X-C chemokine receptor type 1 | IC50 | = | 3800.0 | nM | 5.42 | Antagonist activity at CXCR1 (unknown origin) | 29406702 |
Literature References
Data from ChEMBL 36 via Core Engine